Abstract

BackgroundHuman bocavirus species 1–4 (HBoV1–4) have been associated with respiratory and enteric infections in children. However, the immunological mechanisms in response to HBoV infections are not fully understood. Though previous studies have shown cross-reactivities between HBoV species, the epitopes responsible for this phenomenon remain unknown. In this study, we used genomic and immunologic approaches to identify the reactive epitopes conserved across multiple HBoV species and explored their potential as the basis of a novel diagnostic test for HBoVs.Methodology/Principal FindingsWe generated HBoV1–3 VP2 gene fragment phage display libraries (GFPDLs) and used these libraries to analyze mouse antisera against VP2 protein of HBoV1, 2, and 3, and human sera positive for HBoVs. Using this approach, we mapped four epitope clusters of HBoVs and identified two immunodominant peptides–P1 (1MSDTDIQDQQPDTVDAPQNT20), and P2 (162EHAYPNASHPWDEDVMPDL180)–that are conserved among HBoV1–4. To confirm epitope immunogenicity, we immunized mice with the immunodominant P1 and P2 peptides identified in our screen and found that they elicited high titer antibodies in mice. These two antibodies could only recognize the VP2 of HBoV 1–4 in Western blot assays, rather than those of the two other parvoviruses human parvovirus B19 and human parvovirus 4 (PARV4). Based on our findings, we evaluated epitope-based peptide-IgM ELISAs as potential diagnostic tools for HBoVs IgM antibodies. We found that the P1+P2-IgM ELISA showed a higher sensitivity and specificity in HBoVs IgM detection than the assays using a single peptide.Conclusions/SignificanceThe identification of the conserved B-cell epitopes among human bocavirus species contributes to our understanding of immunological cross-reactivities of HBoVs, and provides important insights for the development of HBoV diagnostic tools.

Highlights

  • Human bocavirus (HBoV) was first identified in nasopharyngeal samples of children with acute respiratory-tract infections (ARTIs) in 2005

  • HBoV VP2 epitopes identified by gene fragment phage display libraries (GFPDLs) panning To identify antigenic clusters, we performed panning of GFPDLs with mouse antisera against VP2 protein of HBoV species 1 (HBoV1), 2 and 3, as well as human sera positive for HBoVs

  • We found that the epitopes located at aa 1–20 in cluster I, and aa 162–180 in cluster II were present in HBoV1, 2, and 3

Read more

Summary

Introduction

Human bocavirus (HBoV) was first identified in nasopharyngeal samples of children with acute respiratory-tract infections (ARTIs) in 2005. This first virus was later designated as HBoV species 1 (HBoV1) [1]. A case of life-threatening HBoV infection has been described in a pediatric patient with pneumothorax and acute respiratory failure in Slovenia [15] These cases indicate that HBoVs may be etiological agents that can lead to severe and life-threatening diseases. A more recent longitudinal study of healthy children from infancy to early adolescence indicated that HBoV1 primary infection is significantly associated with ARTIs and otitis [16].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.